Delivery Order SPE2DB20D1004-SPE2DB25FNJSS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,182.92 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on July 30, 2025, with a completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. The contract carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $36,390.38 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on July 25, 2025, with completion scheduled for July 28, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to the prime contractor. The pharmaceutical product will be delivered to the company's place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $1,117.20 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes management medication. This competitively awarded, firm fixed-price contract was executed on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract carries no set-aside designation and represents a discrete order fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Januvia 50 mg tablets (90-count units) valued at $8,972.46 under a firm fixed-price contract structure. This non-set-aside award represents a child delivery order executed against AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $2,728.65 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and represents a pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a $7,401.38 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,799.66 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), a $999.99 billion vehicle extending through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,091.46 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement for pharmaceutical supply to federal medical systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order under its...
- The Defense Logistics Agency awarded a delivery order valued at $5,449.74 to AmerisourceBergen Drug Corp for Januvia 50 mg tablets (90-unit package) with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and utilizes AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania as the place of performance. The contract represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a $4,365.84 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 50 mg on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's broader pharmaceutical supply...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNJSSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,248.31 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 50 mg on July 29, 2025, with a completion date of July 30, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is listed as Conshohocken, Pennsylvania, which is also the vendor's corporate headquarters location. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive prime vendor agreement enables AmerisourceBergen to supply pharmaceutical products and medical supplies globally to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery order exemplifies the company's role as a critical vendor within the federal medical supply chain, fulfilling individual medication requests drawn from its expansive IDC framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 7/29/25 |